Prize for Innovation in Pediatric Diabetes Care
Nominations for the 2026 ISPAD Prizes are now closed.
This prize is kindly supported by
The prize winner will be invited to attend ISPAD’s Annual Conference to officially receive the award at ISPAD’s Networking & Recognition Evening. ISPAD will cover registration, Economy travel, and accommodation.
ISPAD is honored to announce that 2026 ISPAD Prize for Innovation in Pediatric Diabetes Care winner is:
NICH Program
Dr. Michael A. Harris, Professor of Pediatrics at Oregon Health & Science University (OHSU) and Dr. Kim Spiro, Associate Professor of Pediatrics at OHSU co-developed the NICH program, an evidence-based model that delivers intensive community and home-based interventions for youth living with diabetes who also face significant social challenges. NICH is specifically designed to serve the most vulnerable youth, those whose diabetes management is impacted by circumstances out of their control, such as housing and food insecurity, transportation challenges, caregiver stress and limited access to healthcare. By addressing these underlying social drivers of health, NICH helps families overcome obstacles that would otherwise make effective diabetes management nearly impossible.
NICH has aligned its outcomes with the Institute for Healthcare Improvement’s quintuple aim including reducing costs, improving care, improving health, reducing provider burnout, and advancing health equity. NICH has achieved notable results, including significant reductions in total healthcare expenditures, decreases in diabetic ketoacidosis (DKAs) and A1Cs, improved access to diabetes technology, fewer no-shows to diabetes clinic appointments and overall, reduced burden on families managing daily living alongside diabetes challenges.
NICH has been successfully implemented at Lucile Packard Children’s Hospital, Stanford, and Benioff Children’s Hospitals, UCSF. The program has received several accolades, including the 2015 Clinical Innovation Award from the Association of American Medical Colleges, the 2017 Inaugural Press Ganey Award for Pediatric Excellence, and was a winner of the 2023 American Diabetes Association Scientific Sessions Inaugural Innovation Challenge.
The program has received funding from the Leona M. and Harry B. Helmsley Charitable Trust (HCT), American Diabetes Association (ADA), and Breakthrough T1D (formerly JDRF). In June of 2017, Michael was awarded the Richard R. Rubin Award by the American Diabetes Association that recognizes a behavioral researcher who has made outstanding and innovative contribution in the study and understanding of behavioral aspects of diabetes which largely included his work on NICH.
While Michael and Kim co-founded NICH, its success is the result of the dedication and expertise of many others. Whether it’s providing direct support to patients and families, supervising implementation, conducting outcomes research, advocating with healthcare leaders, seeking and applying for funding, disseminating NICH to new institutions, or sharing the powerful stories of the families we serve with stakeholders, every contribution has been essential. This award reflects the collective efforts of an extraordinary community of clinicians, researchers, leaders, partners, and families who have helped NICH grow and thrive. It truly takes a village.
Previous winners
2023: ISPAE Diabetes Education And Learning (IDEAL), India
2022: Action4Diabetes - Charles Toomey and Jerry Gore
2021: Osagie Ebekozien, USA
2020: Henk J. Aanstoot and Henk Veeze, Netherlands
2019: Peter Goss, Australia
2018: Bruce Buckingham, USA
2017: Peter Adolfsson, Sweden
2016: SWEET Consortium, international
2015: Roman Hovorka, UK
2014: Henrik Mortensen, Denmark
2013: Reinhard Holl, Germany
2012: Center for Rare Forms of Diabetes EXETER, UK
2011: Nicholas Woolfield, Australia
2010: Manuel Vera Gonzalez, Cuba
How to nominate a candidate for this prize?
Nominations for this category can be submitted by ISPAD members. A person can be nominated only by a third party. No self-nominations will be accepted.
The nominator should provide all documents below (in English):
- A letter from the person/institution issuing the nomination specifying the reason for the nomination. The letter should highlight the innovation and describe how different it is from what has been established, its impact on care and change of the current practice, its significance for diabetes care, and how significant or needed this innovation is.
- The complete CV of the candidate.
Send all the documents mentioned above to [email protected].
Eligibility criteria
- Current ISPAD member and ISPAD membership (individual or the organization’s members) for at least 50% of the last 2 years or professional relation between ISPAD and the organization
- All professions
- Candidates can be from any country
- There are no age restrictions